September 1999
This Is No Fish Story
The tale of Centocor is the latest reminder that the road to biotech success is seldom straight. Despite the best business plans, something keeps getting in the way. It's called biology.
By Stephen S. Hall
When big fish Johnson & Johnson announced plans to swallow little fish Centocor in July, it was more than just a typical transaction in biotechnology's food chain. It marked, at least indirectly, the latest chapter in one of biotech's most intriguing and edifying shaggy-dog stories.
![]() | Select from the choices above to read the entire article. |
Customer Service
|
Magazine Services
|
Subscribe
|
Other
|
Advertise
|


